209 related articles for article (PubMed ID: 33543158)
1. Paget's disease of bone: A clinical update.
Cook SJ; Wall C
Aust J Gen Pract; 2021; 50(1-2):23-29. PubMed ID: 33543158
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of Paget's disease of bone: a mini-review.
Ferraz-de-Souza B; Correa PH
Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):577-82. PubMed ID: 24343625
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in the management of Paget's disease.
Ralston SH
Bone; 2020 Sep; 138():115465. PubMed ID: 32512166
[TBL] [Abstract][Full Text] [Related]
4. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
Cronin O; Forsyth L; Goodman K; Lewis SC; Keerie C; Walker A; Porteous M; Cetnarskyj R; Ranganath LR; Selby PL; Hampson G; Chandra R; Ho S; Tobias JH; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia G; Di Stefano M; Guañabens N; Blanch J; Seibel MJ; Walsh JP; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist NL; Boers M; Murray GD; Charnock K; Wilkinson D; Russell RGG; Ralston SH
BMJ Open; 2019 Sep; 9(9):e030689. PubMed ID: 31488492
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ Study.
Tan A; Goodman K; Walker A; Hudson J; MacLennan GS; Selby PL; Fraser WD; Ralston SH;
J Bone Miner Res; 2017 Jun; 32(6):1165-1173. PubMed ID: 28176386
[TBL] [Abstract][Full Text] [Related]
6. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone.
Langston AL; Campbell MK; Fraser WD; MacLennan GS; Selby PL; Ralston SH;
J Bone Miner Res; 2010 Jan; 25(1):20-31. PubMed ID: 19580457
[TBL] [Abstract][Full Text] [Related]
8. The evaluation and treatment of Paget's disease of bone.
Singer FR
Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101506. PubMed ID: 32291204
[TBL] [Abstract][Full Text] [Related]
9. Skeletal dissemination in Paget's disease of the spine.
Rolvien T; Butscheidt S; Zustin J; Amling M
Eur Spine J; 2018 Jul; 27(Suppl 3):453-457. PubMed ID: 29344730
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America.
Werner de Castro GR; Heiden GI; Zimmermann AF; Morato EF; Neves FS; Toscano MA; de Magalhães Souza Fialho SC; Pereira IA
Rheumatol Int; 2012 Mar; 32(3):627-31. PubMed ID: 21127877
[TBL] [Abstract][Full Text] [Related]
11. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
12. The use of zoledronic acid for Paget's disease of bone.
Maricic M
Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
[TBL] [Abstract][Full Text] [Related]
13. Management of Paget's disease of bone.
Reid IR
Osteoporos Int; 2020 May; 31(5):827-837. PubMed ID: 31848640
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
15. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
Gkouva L; Andrikoula M; Kontogeorgakos V; Papachristou DJ; Tsatsoulis A
Clin Rheumatol; 2011 Jan; 30(1):139-44. PubMed ID: 20886248
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.
Ralston SH; Corral-Gudino L; Cooper C; Francis RM; Fraser WD; Gennari L; Guañabens N; Javaid MK; Layfield R; O'Neill TW; Russell RGG; Stone MD; Simpson K; Wilkinson D; Wills R; Zillikens MC; Tuck SP
J Bone Miner Res; 2019 Apr; 34(4):579-604. PubMed ID: 30803025
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, diagnostic evaluation and responses to treatment in Paget's disease of bone in a center specialized in bone metabolism.
Sarli M; Collaceli MD; Jerkovich F; Rey P; Spivacow R; Zanchetta MB
Medicina (B Aires); 2022; 82(3):408-414. PubMed ID: 35639062
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Biochemical, Radiological, and Genetic Analyses of a Patient with VCP Gene Variant-Induced Paget's Disease of Bone.
Zhang Y; Gao P; Yan S; Zhang Q; Wang O; Jiang Y; Xing X; Xia W; Li M
Calcif Tissue Int; 2022 Apr; 110(4):518-528. PubMed ID: 34800131
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
Ang G; Feiglin D; Moses AM
Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
